Real-time enrollment status for this c3 glomerulopathy clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 10:03 AM UTC
| NCT Number | NCT03955445 |
| Recruiting Status | Recruiting |
| Condition | C3 glomerulopathy |
| Phase | PHASE3 |
| Target Enrollment | 225 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | August 7, 2026 (Aug 7, 2026) |
As of October 17, 2026: Clinical trial NCT03955445 is currently recruiting participants. This phase3 study for c3 glomerulopathy is actively seeking new participants at 5 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03955445 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03955445 was last updated Aug 7, 2026 (August 7, 2026). HelloStudys verifies this status automatically.